Jessica Perhanidis
4PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 17, 2025
Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer.Ritu Salani, Tirza Areli Calderón Boyle, Jonathan Lim
|Nov 18, 2024
Real-world overall survival in second-line maintenance niraparib monotherapy versus active surveillance in patients with BRCA wild-type recurrent ovarian cancer.Robert L Coleman, Jessica A Perhanidis, Linda Kalilani
|Jun 09, 2023
Association of Multiple High-Risk Factors on Observed Outcomes in Real-World Patients With Advanced Ovarian Cancer Treated With First-Line Therapy.Dana Chase, Jessica Perhanidis, Divya Gupta
|Apr 04, 2023
Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance.Dana Chase, Jessica Perhanidis, Divya Gupta
Pageof 1
